Morgan Stanley raised the firm’s price target on Confluent (CFLT) to $32 from $30 and keeps an Equal Weight rating on the shares. Q4 results came in ahead of consensus across all key metrics, but represented “the smallest beat of the year,” the analyst tells investors. While adding that guidance was “more impressive,” the firm contends that the key debate is how much upside is there to 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CFLT:
- Confluent price target raised to $40 from $31 at Needham
- Confluent price target raised to $37 from $32 at Baird
- Confluent price target raised to $40 from $37 at Stifel
- Confluent price target raised to $38 from $35 at Guggenheim
- Confluent: Strong Q4 Performance, Strategic Partnerships, and Promising Growth Justify Buy Rating